As oncology professionals, we strive to improve survival and quality of life in all patients. June has several events to remind us of the rights of people of all colors (Juneteenth [June 19]—the anniversary of when the end of slavery in Texas was finally enforced), age (June 15—World Elder Abuse Awareness Day ), and gender […]

For some solid tumors, identification of genomic alterations susceptible to drug therapy has improved clinical outcomes. This has led to increased interest in next-generation sequencing (NGS) testing to identify patients who qualify for enrollment in biomarker-selected clinical trials. In the Michigan Oncology Sequencing Program (Mi-ONCOSEQ), a cohort study of 1015 patients who underwent integrative genomic […]

Exciting new developments emerge from the oncology and hematology fields constantly. While many changes unfold over time, some announcements, new discoveries, and novel products are unveiled at annual conferences. Major oncology conferences include those of the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). Important hematology conferences include the […]

Interest in and access to telemedicine has gained momentum in recent years, especially during the COVID-19 pandemic. New diagnostic and communication technologies have greatly improved the capabilities and quality of available interventions. In fact, studies have demonstrated that telemedicine is equivalent to—or at times, achieves better outcomes than—in-person care, with improved cost-effectiveness, greater convenience, and […]

As reported previously, clinical trial enrollments decreased in the midst of the COVID-19 pandemic, primarily due to concerns about contagion. To examine the attitudes of cancer survivors toward trial participation, Dr Mark Fleury et al surveyed a large group of patients from the American Cancer Society Cancer Action Network’s Survivor Views panel in mid-2020. The […]